Polymorphisms of the DNA repair gene XPD (751) and XRCC1 (399) correlates with risk of hematological malignancies in turkish population

African Journal of Biotechnology

Volumn 10, Issue 44, 2011, Pages 8860-8870

  Özcan, Ali ^a   Pehlivan, Mustafa ^b   Tomatir, Ayse Gaye ^c   Karaca, E ^a   Özkinay, Cihangir ^a   Özdemir, Filiz ^a   Pehlivan, Sacide ^a,b  

^a EGE UNIVERSITY   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

^c PAMUKKALE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

DNA; DNA repair; PCR RFLP; XPD gene; XRCC1 gene

Indexed keywords

GLYCINE; LYSINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CODON; CONTROLLED STUDY; DNA POLYMORPHISM; EXCISION REPAIR; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC DIFFERENCE; GENETIC VARIABILITY; HAPLOTYPE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; LEUKEMIA RELAPSE; MAJOR CLINICAL STUDY; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; ONCOGENE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC); X RAY REPAIR CROSS COMPLEMENTING GROUP 1 GENE; XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP D GENE;

EID: 80051747372     PISSN: 16845315     EISSN: None     Source Type: Journal    
DOI: 10.5897/ajb10.1839     Document Type: Article

References (57)

1. Allan JM, Smith AG, Wheatley K, Hills RK, Travis LB, Hill DA, Travis LB, Hill DA, Swirsky DM, Morgan GJ, Wild CP (2004). Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood, 104: 3872-3877.
2. Andrew AS, Karagas MR, Nelson HH, Guarrera S, Polidoro S, Gamberini SSacerdote C, Moore JH, Kelsey KT, Demidenko E, Vineis P and Matullo G (2008). DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Hum. Hered. 65: 105-118.
3. Artac M, Bozcuk H, Pehlivan S, Akcan S, Pehlivan M, Sever T, Ozdogan M, Savas B (2010). The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens. J. Cancer Res. Clin. Oncol. 136: 803-809.
4. Baccaralli A, Calista D, Minghetti P, Albetti B, Tseng T, Hedayati M Grossman L, Landi G, Struwing JP, Landi MT (2004). XPD gene polymorphism and host characteristics in the association with cutaneous malignant melonoma risk. Br. J. Cancer. 90: 497-502.
5. Butkiewicz D, Rusin M, Enewold I, Shields PG, Chorazy M, Harris CC (2001). Genetic Polimorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis, 22: 543-597.
6. Chacko P, Rajan B, Joseph T, Mathew BS, Pillai MR (2005). Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res. Treat. 89: 15-21.
7. Das-Gupta EP, Seedhouse CH, Russell NH (2000). DNA repair mechanisms and acute myeloblastic leukemia. Hematol. Oncol. 18: 99-110.
8. David-Beabes GL, London SJ (2001). Genetic polymorphism of XRCC1 and lung cancer risk among African-Americans and Caucasians. Lung Cancer, 34: 333-339.
9. De las Peñas R, Sanchez-Ronco M, Alberola V, Taron M, Camps C, Garcia-Carbonero R, Massuti B, Queralt C, Botia M, Garcia-Gomez R, Isla D, Cobo M, Santarpia M, Cecere F, Mendez P, Sanchez JJ, Rosell R (2006). Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients. Ann. Oncol. 17: 668-675.
10. Duell EJ, Holly EA, Bracci PM, Wiencke JK, Kelsey KT (2002). A population-based study of the Arg399Gln polymorphism in x-ray repair cross-complementing group 1 (XRCC1) and risk of pancreatic adenocarcinoma Cancer Res. 62: 4630-4636.
11. Duell EJ, Millikan RC, Pittman GS, Winkel S, Lunn RM, Tse CK, Tse CKJ, Aeton A, Mohrenweiser HW, Newman B, Bell DA (2001). Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol. Biomarkers Prev. 10: 217-222.
12. Duell EJ, Wiencke JK, Cheng TJ, Varkonyi A, Zuo ZF, Ashok TD, Mark EJ, Wain JC, Christiani DC, Kelsey K (2000). Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis, 21: 965-971.
13. Gao WM, Romkes M, Day RD, Siegfried JM, Luketich JD, Mady HH, Melhem M F, Keohavong P (2003). Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer. Carcinogenesis, 24: 1671-1676.
14. Hemminki K, Xu G, Angelini S, Snellman E, Jansen CT, Lambert B, Hou S-M (2001). XPD exon 10 and 23 polymorphisms and DNA repair in human skin in situ. Carsinogenesis, 22: 1185-1188.
15. Hou SM, Fält S, Angelini S, Yang K, Nyberg F, Lambert B, Hemminki K (2002). The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis, 23: 599-603.
16. Hsieh YY, Chang CC, Bau DT, Yeh LS, Tsai FJ, Tsai CH (2008). X-ray repair cross-complementing group 4 (XRCC4) promoter -1394(*) Trelated genotype, but not XRCC4 codon 247/intron 3 or xeroderma pigmentosum group D codon 312, 751/promoter -114, polymorphisms are correlated with higher susceptibility to myoma. Fertil. Steril. 90: 1417-1423.
17. Hu Z, Wei Q, Wang X, Shen H (2004). DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis. Lung Cancer, 46: 1-10.
18. Jiao L, Hassan MM, Bondy ML, Abbruzzese JL, Evans DB, Li D (2007). The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. Cancer Lett. 245: 61-68.
19. Kalikaki A, Kanaki M, Vassalou H, Souglakos J, Voutsina A, Georgoulias V, Mavroudis D (2009). DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer. Clin. Lung Cancer, 10: 118-123.
20. Kumar R, Angelini S, Hemminki K (2003). Simultaneous detection of the exon 10 polymorphism and a novel intronic single base insertion polymorphism in the XPD gene using single strand conformation polymorphism. Mutagenesis, 18: 207-209.
21. Lei YC, Hwang SJ, Chang CC, Kuo HW, Luo JC, Chang MJ, Cheng TJ (2002). Effects on sister chromatid exchange frequency of polymorphisms in DNA repair gene XRCC1 in smokers. Mutat. Res. 519: 93-101.
22. Liang G, Xing D, Miao X, Tan W, Yu C, Lu W, Lin D (2003). Sequence variations in the DNA repair gene XPD and risk of lung cancer in a chinese population. Int. J. Cancer, 105: 669-673.
23. McCarty KM, Smith TJ, Zhou W, Gonzalez E, Quamruzzaman Q, Rahman M, et al (2007). Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions. Carcinogenesis, 28: 1697-1702.
24. Mechanic LE, Millikan RC, Player J, de Cotret AR, Winkel S, Worley K Heard K, Heard K, Tse CK, Keku T (2006). Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis, 27: 1377-1385.
25. Mehta PA, Alonzo TA, Gerbing RB, Elliott JS, Wilke TA, Kennedy RJ Ross JA, Perentesis JP, Lange BJ and Davies SM (2006). XPD Lys751Gln polymorphism in the etiology and outcome of childhood acute myeloid leukemia: a Children's Oncology Group report. Blood, 107: 39-45.
26. Metsola K, Kataja V, Sillanpää P, Siivola P, Heikinheimo L, Eskelinen M Kosma V-M, Uusitupa M, Hirvonen A (2005). XRCC1 and XPD genetic polymorphisms, smoking and brest cancer risk in a Finnish case-control study. Breast Cancer Res. 7: 987-997.
27. Monzo M, Brunet S, Urbano-Ispizua A, Navarro A, Perea G, Esteve J, Artells R, Granell M, Berlanga J, Ribera JM, Bueno J, Llorente A, Guardia R, Tormo M, Torres P, Nomdedéu JF, Montserrat E, Sierra J (2006). Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia. Blood, 107: 4871-4879.
28. Moullan N, Cox DG, Angele S, Romestaing P, Gerard JP, Hall J (2003). Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiothrapy. Cancer Epidemiol. Biomarkers Prev. 12: 1168-1174.
29. Park JY, Lee SY, Jeon HS, Bae NC, Chae SC, Joo S, Kim CH, Park JH, Kam S, Kim I-S, Jung TH (2002a). Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev. 11: 23-27.
30. Park JY, Lee SY, Jeon HS, Park SH, Bae NC, Lee EB Cha SI, Park H, Kam S, Kim I-S, Jung TH (2002b). Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer. Lung Cancer, 36: 15-16.
31. Pedersen-Bjergaard J, Andersen MK, Chistiansen DH, Nerlov C (2002). Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood, 99: 1909-1912
32. Qiao Y, Spitz MR, Shen H, Guo Z, Shete S, Hedayati M Grossman L, Mohrenweiser H, Wei Q (2002). Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis, 23: 295-299.
33. Ruzzo A, Canestrari E, Maltese P, Pizzagalli F, Graziano F, Santini D Catalano V, Ficarelli R, Mari D, Bisonni R, Giordani P, Giustini L, Lippe P, Silva R, Mattioli R, Torresi U, Latini L, Magnani M (2007). Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer. Clin. Chem. Lab. Med. 45: 822-828.
34. Rybicki BA, Conti DV, Moreira A, Cicek M, Casey G, Witte JS (2004). DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev. 13: 23-29.
35. Rzeszowska-Wolny J, Polanska J, Pietrowska M, Palyvoda O, Jaworska J, Butkiewicz D, Hancock R (2005). Influence of polymorphisms in DNA repair genes XPD, XRCC1 and MGMT on DNA damage induced by gamma radiation and its repair in lymphocytes in vitro. Radiat. Res. 164:132-140.
36. Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das-gupta E (2002). The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute Özcan et al. 8869 myeloblastic leukemia. Blood. 100: 3761-3766.
37. Seedhouse C, Faulkner R, Ashraf N, Das-gupta E, Russell N (2004). Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin. Cancer Res. 10: 2675-2680.
38. Seedhouse C, Russell N (2007). Advances in the understanding of susceptibility to treatment-related acute myeloid leukaemia. Br. J. Haematol. 137: 513-529.
39. Seker H, Butkiewicz D, Bowman ED, Rusin M, Hedayati M, Grossman L Haris CC (2001). Functional Significance of XPD Polymorphic Variants: Attenuated Apoptosis in Human Lymphoblastoid Cells with the XPD 312 Asp/Asp Genotype. Cancer Res. 61: 7430-7434.
40. Shen M, Hung RJ, Brennan P, Malaveille C, Donato F, Placidi D, Carta A, Hautefeuille A, Boffetta P, Porru S (2003). Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with enviromental exposures, and bladder cancer risk in a case-control study in Northern Italy. Cancer Epidemiol. Biomarkers Prev. 12: 1234-1240.
41. Shi Q, Wang LE, Bondy M, Brewster A, Singletary SE, Wei Q (2004). Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adduct and common XPD polymorphisms in breast cancer patient. Carcinogenesis, 25: 1695-1700.
42. Skjelbred CF, Sæbø M, Wallin H, Nexø BA, Hagen PC, Lothe IM, Aase S, Johnson E, Hansteen I-L, Vogel U, Kure EH (2006). Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carsinoma, in Norwegian cohort: a case control study. BMC Cancer, 6: p. 67.
43. Smith AG, Worrillow LJ, Allan JM (2007). A common genetic variant in XPD associates with risk of 5q- and 7q-deleted acute myeloid leukemia. Blood. 109: 1233-1236.
44. Smith TR, Levine EA, Perrier ND, Miller MS, Freimanis RI, Lohman K, Case LD, Xu J, Mohrenweiser HW, Hu JJ (2003a). DNA-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol. Biomarkers Prev. 12: 1200-1204.
45. Smith TR, Miller MS, Lohman K, Lange EM, Case LD, Mohrenweiser HW, Hu JJ (2003b). Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett. 190: 183-190.
46. Sreeja L, Syamala VS, Syamala V, Hariharan S, Raveendran PB, Vijayalekshmi RV, Madhavan J, Ankathil R (2008). Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J. Cancer Res. Clin. Oncol. 134: 645-652.
47. Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA (2001). DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 10: 125-131.
48. Stern MC, Umbach DM, Lunn RM, Taylor JA (2002). DNA repair gene XRCC3 codon 241 polymorphism, its i{dotless}nteraction with smoking and XRCC1 polimorphisms, and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 11: 939-943.
49. Tae K, Lee HS, Park BJ, Park CW, Kim KR, Cho HY Kim LH, Park BL, Shin HD (2004). Association of DNA repair gene XRCC1 polymorphisms with head and neck cancer in Korean population. Int. J. Cancer. 111: 805-808.
50. Taylor EM, Broughton BC, Botta E, Stefanini M, Sarasin A, Jaspers NG, Fawcett H, Harcourt S, Arlett CF, Lehmann AR (1997). Xeroderma pigmentosum and trichothiodystrophy are associated with different mutations in the XPD (ERCC2) repair/transcription gene. Proc. Natl. Acad. Sci. USA. 94: 8658-8663.
51. Taylor EM, Lehmann AR (1998). Conservation of eukaryotic DNA repair mechanisms. Int. J. Radiat Biol. 74: 277-286.
52. Unal M, Güven M, Batar B, Ozaydin A, Sarici A, Devranoǧlu K (2007). Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development. Exp. Eye Res. 85: 328-334.
53. Xing D, Tan W, Wei Q, Lin D (2002). Polymorphisms of the DNA repair gene XPD and risk of lung cancer in a Chinese population. Lung Cancer, 38: 123-129.
54. Yang ZH, Du B, Wei YS, Zhang JH, Zhou B, Liang WB, Zhang BL, Zhang L (2007). Genetic polymorphisms of the DNA repair gene and risk of nasopharyngeal carcinoma. DNA Cell Biol. 26: 491-496.
55. Ye W, Kumar R, Bacova G, Lagergren J, Hemminki K, Nyrén O (2006). The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden. Carcinogenesis, 27: 1835-1841.
56. Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL (2005). Polymorphisms of the XRCC1, XRCC3, & XPD genes and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer, 5: p. 12.
57. Yu HP, Zhang XY, Wang XL, Shi LY, Li YY, Li F Su Y-H, Wang Y-J, Lu B, Sun X, Lu W-H, Xu S-Q (2004). DNA repair gene XRCC1 polymorphisms, smoking, and esophageal cancer risk. Cancer Detect Prev. 28: 194-199